These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 12664783)

  • 1. [Use of peg-intron in combined treatment of chronic liver disease caused by HIV infection].
    Pomova NI; Ivanikov IO; Siutkin VE
    Eksp Klin Gastroenterol; 2003; (1):42-5, 182. PubMed ID: 12664783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peginterferon plus ribavirin for hepatitis C in HIV-infected patients.
    Gholam PM
    N Engl J Med; 2004 Nov; 351(22):2340-2; author reply 2340-2. PubMed ID: 15570682
    [No Abstract]   [Full Text] [Related]  

  • 3. Treatment of hepatitis C in HIV-infected patients: significant progress but not the final step.
    Manns MP; Wedemeyer H
    JAMA; 2004 Dec; 292(23):2909-13. PubMed ID: 15598923
    [No Abstract]   [Full Text] [Related]  

  • 4. Undetectable hepatitis C virus RNA at week 4 as predictor of sustained virological response in HIV patients with chronic hepatitis C.
    Martin-Carbonero L; Nuñez M; Mariño A; Alcocer F; Bonet L; García-Samaniego J; López-Serrano P; Cordero M; Portu J; Soriano V
    AIDS; 2008 Jan; 22(1):15-21. PubMed ID: 18090387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pegylated interferon alfa-2b vs standard interferon alfa-2b, plus ribavirin, for chronic hepatitis C in HIV-infected patients: a randomized controlled trial.
    Carrat F; Bani-Sadr F; Pol S; Rosenthal E; Lunel-Fabiani F; Benzekri A; Morand P; Goujard C; Pialoux G; Piroth L; Salmon-Céron D; Degott C; Cacoub P; Perronne C;
    JAMA; 2004 Dec; 292(23):2839-48. PubMed ID: 15598915
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sustained virologic response with short-course ribavirin and peginterferon treatment in 2 patients coinfected with HIV and HCV genotype 1.
    Patel MR; Mullen MP; Dieterich DT
    AIDS Read; 2006 Mar; 16(3):164, 168-9; discussion 168-9. PubMed ID: 16538956
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Open, randomized, multicentre italian trial on PEG-IFN plus ribavirin versus PEG-IFN monotherapy for chronic hepatitis C in HIV-coinfected patients on HAART.
    Cargnel A; Angeli E; Mainini A; Gubertini G; Giorgi R; Schiavini M; Duca P;
    Antivir Ther; 2005; 10(2):309-17. PubMed ID: 15865225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of peg-IFN alfa-2a with ribavirin for the treatment of HCV/HIV coinfected patients who failed previous IFN based therapy.
    Rodríguez-Torres M; Rodríguez-Orengo JF; Ríos-Bedoya CF; Fernández-Carbia A; González-Lassalle E; Salgado-Mercado R; Marxuach-Cuétara AM
    J Clin Virol; 2007 Jan; 38(1):32-8. PubMed ID: 17064957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regression of liver fibrosis in hepatitis C virus/HIV-co-infected patients after treatment with pegylated interferon plus ribavirin.
    Soriano V; Labarga P; Ruiz-Sancho A; Garcia-Samaniego J; Barreiro P
    AIDS; 2006 Nov; 20(17):2225-7. PubMed ID: 17086063
    [No Abstract]   [Full Text] [Related]  

  • 10. Ribavirin in combination therapy for HCV chronic infection in HIV patients: how to win the war after winning the first battle?
    Souvignet C; Maynard M; Gagnieu MC; Trepo C
    J Hepatol; 2007 Jul; 47(1):1-3. PubMed ID: 17509722
    [No Abstract]   [Full Text] [Related]  

  • 11. [Clinical response to etiotropic therapy of chronic viral hepatitis C].
    Gromova NI; Bogomolov BP
    Klin Med (Mosk); 2003; 81(1):48-51. PubMed ID: 12650097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of chronic hepatitis C in southern Taiwan.
    Chuang WL; Yu ML; Dai CY; Chang WY
    Intervirology; 2006; 49(1-2):99-106. PubMed ID: 16166797
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis C virus-RNA clearance in HIV-coinfected patients with chronic hepatitis C treated with pegylated interferon plus ribavirin.
    Soriano V; Núñez M; Camino N; Maida I; Barreiro P; Romero M; Martin-Carbonero L; Garcia-Samaniego J; González-Lahoz J
    Antivir Ther; 2004 Aug; 9(4):505-9. PubMed ID: 15456081
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors of alpha-fetoprotein elevation in patients with chronic hepatitis C, but not hepatocellular carcinoma, and its normalization after pegylated interferon alfa 2a-ribavirin combination therapy.
    Chen TM; Huang PT; Tsai MH; Lin LF; Liu CC; Ho KS; Siauw CP; Chao PL; Tung JN
    J Gastroenterol Hepatol; 2007 May; 22(5):669-75. PubMed ID: 17444854
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peginterferon Alfa-2a plus ribavirin for chronic hepatitis C virus infection in HIV-infected patients.
    Torriani FJ; Rodriguez-Torres M; Rockstroh JK; Lissen E; Gonzalez-García J; Lazzarin A; Carosi G; Sasadeusz J; Katlama C; Montaner J; Sette H; Passe S; De Pamphilis J; Duff F; Schrenk UM; Dieterich DT;
    N Engl J Med; 2004 Jul; 351(5):438-50. PubMed ID: 15282351
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peginterferon plus ribavirin for hepatitis C in HIV-infected patients.
    Taylor LE; Rich JD; Tashima KT
    N Engl J Med; 2004 Nov; 351(22):2340-2; author reply 2340-2. PubMed ID: 15564553
    [No Abstract]   [Full Text] [Related]  

  • 17. Fulminant autoimmune hepatitis after successful interferon treatment in an HIV-HCV co-infected patient.
    Coriat R; Podevin P
    Int J STD AIDS; 2008 Mar; 19(3):208-10. PubMed ID: 18397566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Occult HBV infection and suppression of HCV replication in the early phase of combination therapy for chronic hepatitis C.
    Ferraro D; Bonura C; Giglio M; Di Stefano R; Almasio PL; Di Marco V; Craxì A; Cacciola I; Squadrito G; Raimondo G
    J Biol Regul Homeost Agents; 2003; 17(2):172-5. PubMed ID: 14518718
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treating hepatitis C in "difficult-to-treat" patients.
    Pawlotsky JM
    N Engl J Med; 2004 Jul; 351(5):422-3. PubMed ID: 15282348
    [No Abstract]   [Full Text] [Related]  

  • 20. Insulin resistance in HCV mono-infected and in HIV/HCV co-infected patients: Looking to the future.
    Cammà C; Petta S
    J Hepatol; 2009 Apr; 50(4):648-51. PubMed ID: 19231012
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.